nodes	percent_of_prediction	percent_of_DWPC	metapath
Clomifene—CYP1A1—Dacarbazine—sarcoma	0.138	0.182	CbGbCtD
Clomifene—CYP2E1—Dacarbazine—sarcoma	0.107	0.14	CbGbCtD
Clomifene—CYP2E1—Mitoxantrone—sarcoma	0.0826	0.109	CbGbCtD
Clomifene—CYP1A2—Dacarbazine—sarcoma	0.0616	0.0811	CbGbCtD
Clomifene—CYP3A4—Thiotepa—sarcoma	0.0582	0.0767	CbGbCtD
Clomifene—CYP2E1—Etoposide—sarcoma	0.0521	0.0686	CbGbCtD
Clomifene—ABCB1—Dactinomycin—sarcoma	0.0467	0.0615	CbGbCtD
Clomifene—ABCB1—Mitoxantrone—sarcoma	0.0418	0.055	CbGbCtD
Clomifene—CYP1A2—Etoposide—sarcoma	0.0301	0.0397	CbGbCtD
Clomifene—ABCB1—Vincristine—sarcoma	0.0288	0.0379	CbGbCtD
Clomifene—ABCB1—Etoposide—sarcoma	0.0264	0.0347	CbGbCtD
Clomifene—CYP3A4—Mitoxantrone—sarcoma	0.025	0.033	CbGbCtD
Clomifene—ABCB1—Doxorubicin—sarcoma	0.018	0.0237	CbGbCtD
Clomifene—CYP3A4—Vincristine—sarcoma	0.0172	0.0227	CbGbCtD
Clomifene—CYP3A4—Etoposide—sarcoma	0.0158	0.0208	CbGbCtD
Clomifene—CYP3A4—Doxorubicin—sarcoma	0.0108	0.0142	CbGbCtD
Clomifene—ESR1—periosteum—sarcoma	0.00528	0.0917	CbGeAlD
Clomifene—EBP—uterus—sarcoma	0.00303	0.0526	CbGeAlD
Clomifene—EBP—liver—sarcoma	0.00208	0.0361	CbGeAlD
Clomifene—KCNH2—Hematopoietic Stem Cell Differentiation—FLI1—sarcoma	0.00201	0.0785	CbGpPWpGaD
Clomifene—SIGMAR1—mammary gland—sarcoma	0.00178	0.0308	CbGeAlD
Clomifene—CYP11A1—hematopoietic system—sarcoma	0.00169	0.0294	CbGeAlD
Clomifene—CYP11A1—connective tissue—sarcoma	0.00163	0.0283	CbGeAlD
Clomifene—ESR1—mammary gland—sarcoma	0.00157	0.0273	CbGeAlD
Clomifene—CYP2A6—seminal vesicle—sarcoma	0.00148	0.0256	CbGeAlD
Clomifene—SIGMAR1—myometrium—sarcoma	0.00126	0.0219	CbGeAlD
Clomifene—SIGMAR1—seminal vesicle—sarcoma	0.00114	0.0198	CbGeAlD
Clomifene—ESR1—myometrium—sarcoma	0.00111	0.0193	CbGeAlD
Clomifene—CYP19A1—hematopoietic system—sarcoma	0.0011	0.0191	CbGeAlD
Clomifene—ESR1—embryo—sarcoma	0.00107	0.0186	CbGeAlD
Clomifene—CYP19A1—connective tissue—sarcoma	0.00106	0.0184	CbGeAlD
Clomifene—KCNH2—myometrium—sarcoma	0.001	0.0174	CbGeAlD
Clomifene—ESR1—hematopoietic system—sarcoma	0.000956	0.0166	CbGeAlD
Clomifene—SIGMAR1—smooth muscle tissue—sarcoma	0.000953	0.0165	CbGeAlD
Clomifene—KCNH2—Hematopoietic Stem Cell Differentiation—CSF3—sarcoma	0.00095	0.0371	CbGpPWpGaD
Clomifene—CYP19A1—Ovarian Infertility Genes—GJA4—sarcoma	0.000947	0.037	CbGpPWpGaD
Clomifene—CYP11A1—testis—sarcoma	0.000928	0.0161	CbGeAlD
Clomifene—ESR1—connective tissue—sarcoma	0.000921	0.016	CbGeAlD
Clomifene—KCNH2—seminal vesicle—sarcoma	0.000906	0.0157	CbGeAlD
Clomifene—KCNH2—hematopoietic system—sarcoma	0.000861	0.015	CbGeAlD
Clomifene—ESR1—smooth muscle tissue—sarcoma	0.000842	0.0146	CbGeAlD
Clomifene—CYP19A1—uterus—sarcoma	0.000831	0.0144	CbGeAlD
Clomifene—SIGMAR1—cardiac atrium—sarcoma	0.000821	0.0143	CbGeAlD
Clomifene—SIGMAR1—uterus—sarcoma	0.000817	0.0142	CbGeAlD
Clomifene—CYP1A2—hematopoietic system—sarcoma	0.000737	0.0128	CbGeAlD
Clomifene—CYP1A1—hematopoietic system—sarcoma	0.000727	0.0126	CbGeAlD
Clomifene—CYP2A6—liver—sarcoma	0.000727	0.0126	CbGeAlD
Clomifene—ESR1—uterus—sarcoma	0.000722	0.0125	CbGeAlD
Clomifene—SIGMAR1—tendon—sarcoma	0.000716	0.0124	CbGeAlD
Clomifene—CYP2E1—seminal vesicle—sarcoma	0.000698	0.0121	CbGeAlD
Clomifene—SIGMAR1—bone marrow—sarcoma	0.000694	0.012	CbGeAlD
Clomifene—ESR1—lymphoid tissue—sarcoma	0.000673	0.0117	CbGeAlD
Clomifene—CYP11A1—lymph node—sarcoma	0.000673	0.0117	CbGeAlD
Clomifene—CYP2E1—hematopoietic system—sarcoma	0.000663	0.0115	CbGeAlD
Clomifene—KCNH2—cardiac atrium—sarcoma	0.000654	0.0114	CbGeAlD
Clomifene—KCNH2—uterus—sarcoma	0.00065	0.0113	CbGeAlD
Clomifene—CYP1A1—skin of body—sarcoma	0.000632	0.011	CbGeAlD
Clomifene—CYP19A1—testis—sarcoma	0.000603	0.0105	CbGeAlD
Clomifene—ESR1—LKB1 signaling events—EZR—sarcoma	0.000596	0.0233	CbGpPWpGaD
Clomifene—SIGMAR1—testis—sarcoma	0.000593	0.0103	CbGeAlD
Clomifene—CYP19A1—liver—sarcoma	0.00057	0.0099	CbGeAlD
Clomifene—ESR1—FOXA1 transcription factor network—COL18A1—sarcoma	0.000567	0.0222	CbGpPWpGaD
Clomifene—SIGMAR1—liver—sarcoma	0.00056	0.00973	CbGeAlD
Clomifene—CYP1A1—cardiac atrium—sarcoma	0.000552	0.00959	CbGeAlD
Clomifene—KCNH2—bone marrow—sarcoma	0.000552	0.00958	CbGeAlD
Clomifene—CYP1A1—uterus—sarcoma	0.000549	0.00954	CbGeAlD
Clomifene—KCNH2—Hematopoietic Stem Cell Differentiation—CXCR4—sarcoma	0.000543	0.0212	CbGpPWpGaD
Clomifene—CYP3A4—hematopoietic system—sarcoma	0.000534	0.00926	CbGeAlD
Clomifene—ESR1—Signaling mediated by p38-alpha and p38-beta—MITF—sarcoma	0.000533	0.0208	CbGpPWpGaD
Clomifene—ESR1—testis—sarcoma	0.000524	0.0091	CbGeAlD
Clomifene—ESR1—liver—sarcoma	0.000495	0.0086	CbGeAlD
Clomifene—Vision blurred—Thiotepa—sarcoma	0.000479	0.00304	CcSEcCtD
Clomifene—KCNH2—testis—sarcoma	0.000472	0.00819	CbGeAlD
Clomifene—Hepatocellular injury—Epirubicin—sarcoma	0.000468	0.00298	CcSEcCtD
Clomifene—Pulmonary embolism—Epirubicin—sarcoma	0.000468	0.00298	CcSEcCtD
Clomifene—CYP2E1—lymphoid tissue—sarcoma	0.000467	0.00811	CbGeAlD
Clomifene—Renal failure—Etoposide—sarcoma	0.000459	0.00292	CcSEcCtD
Clomifene—Alopecia—Vincristine—sarcoma	0.000457	0.00291	CcSEcCtD
Clomifene—Jaundice—Etoposide—sarcoma	0.000455	0.00289	CcSEcCtD
Clomifene—Arrhythmia—Mitoxantrone—sarcoma	0.00045	0.00286	CcSEcCtD
Clomifene—Alopecia—Mitoxantrone—sarcoma	0.000445	0.00283	CcSEcCtD
Clomifene—Convulsion—Thiotepa—sarcoma	0.00044	0.0028	CcSEcCtD
Clomifene—ABCB1—myometrium—sarcoma	0.00044	0.00764	CbGeAlD
Clomifene—CYP2E1—tendon—sarcoma	0.000439	0.00762	CbGeAlD
Clomifene—Erythema—Mitoxantrone—sarcoma	0.000439	0.00279	CcSEcCtD
Clomifene—Hypertension—Thiotepa—sarcoma	0.000439	0.00279	CcSEcCtD
Clomifene—CYP19A1—lymph node—sarcoma	0.000437	0.00759	CbGeAlD
Clomifene—Back pain—Vincristine—sarcoma	0.000436	0.00277	CcSEcCtD
Clomifene—CYP2E1—Folate-Alcohol and Cancer Pathway—CREB1—sarcoma	0.000435	0.017	CbGpPWpGaD
Clomifene—Pulmonary embolism—Doxorubicin—sarcoma	0.000433	0.00275	CcSEcCtD
Clomifene—Hepatocellular injury—Doxorubicin—sarcoma	0.000433	0.00275	CcSEcCtD
Clomifene—Arthralgia—Thiotepa—sarcoma	0.000433	0.00275	CcSEcCtD
Clomifene—Myalgia—Thiotepa—sarcoma	0.000433	0.00275	CcSEcCtD
Clomifene—Anxiety—Thiotepa—sarcoma	0.000431	0.00274	CcSEcCtD
Clomifene—SIGMAR1—lymph node—sarcoma	0.00043	0.00746	CbGeAlD
Clomifene—Myalgia—Dactinomycin—sarcoma	0.000429	0.00273	CcSEcCtD
Clomifene—Back pain—Mitoxantrone—sarcoma	0.000425	0.0027	CcSEcCtD
Clomifene—Neoplasm—Epirubicin—sarcoma	0.000423	0.00269	CcSEcCtD
Clomifene—ABCB1—embryo—sarcoma	0.000423	0.00735	CbGeAlD
Clomifene—ESR1—Validated nuclear estrogen receptor alpha network—COL18A1—sarcoma	0.00042	0.0164	CbGpPWpGaD
Clomifene—Vision blurred—Mitoxantrone—sarcoma	0.000414	0.00263	CcSEcCtD
Clomifene—Oedema—Dactinomycin—sarcoma	0.000412	0.00262	CcSEcCtD
Clomifene—Mental disability—Epirubicin—sarcoma	0.000406	0.00258	CcSEcCtD
Clomifene—Vertigo—Vincristine—sarcoma	0.000405	0.00257	CcSEcCtD
Clomifene—Tachycardia—Thiotepa—sarcoma	0.000405	0.00257	CcSEcCtD
Clomifene—ABCB1—seminal vesicle—sarcoma	0.000397	0.0069	CbGeAlD
Clomifene—Erythema multiforme—Etoposide—sarcoma	0.000396	0.00252	CcSEcCtD
Clomifene—CYP19A1—FSH signaling pathway—FOXO1—sarcoma	0.000396	0.0155	CbGpPWpGaD
Clomifene—Phlebitis—Epirubicin—sarcoma	0.000394	0.00251	CcSEcCtD
Clomifene—Thrombophlebitis—Epirubicin—sarcoma	0.000393	0.0025	CcSEcCtD
Clomifene—Neoplasm—Doxorubicin—sarcoma	0.000392	0.00249	CcSEcCtD
Clomifene—Convulsion—Vincristine—sarcoma	0.00039	0.00248	CcSEcCtD
Clomifene—Flushing—Etoposide—sarcoma	0.000389	0.00247	CcSEcCtD
Clomifene—Hypertension—Vincristine—sarcoma	0.000389	0.00247	CcSEcCtD
Clomifene—ESR1—Signaling mediated by p38-alpha and p38-beta—ATF1—sarcoma	0.000385	0.0151	CbGpPWpGaD
Clomifene—Myalgia—Vincristine—sarcoma	0.000384	0.00244	CcSEcCtD
Clomifene—CYP1A2—liver—sarcoma	0.000382	0.00663	CbGeAlD
Clomifene—Convulsion—Mitoxantrone—sarcoma	0.00038	0.00242	CcSEcCtD
Clomifene—ESR1—lymph node—sarcoma	0.00038	0.0066	CbGeAlD
Clomifene—Hypertension—Mitoxantrone—sarcoma	0.000379	0.00241	CcSEcCtD
Clomifene—Musculoskeletal discomfort—Thiotepa—sarcoma	0.000378	0.0024	CcSEcCtD
Clomifene—ABCB1—hematopoietic system—sarcoma	0.000378	0.00656	CbGeAlD
Clomifene—CYP1A1—liver—sarcoma	0.000377	0.00654	CbGeAlD
Clomifene—Eye pain—Epirubicin—sarcoma	0.000376	0.00239	CcSEcCtD
Clomifene—Mental disability—Doxorubicin—sarcoma	0.000376	0.00239	CcSEcCtD
Clomifene—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.000375	0.00238	CcSEcCtD
Clomifene—Myalgia—Mitoxantrone—sarcoma	0.000374	0.00238	CcSEcCtD
Clomifene—Chest pain—Mitoxantrone—sarcoma	0.000374	0.00238	CcSEcCtD
Clomifene—Arthralgia—Mitoxantrone—sarcoma	0.000374	0.00238	CcSEcCtD
Clomifene—Paraesthesia—Thiotepa—sarcoma	0.000372	0.00237	CcSEcCtD
Clomifene—Anxiety—Mitoxantrone—sarcoma	0.000372	0.00237	CcSEcCtD
Clomifene—Alopecia—Etoposide—sarcoma	0.000371	0.00236	CcSEcCtD
Clomifene—Oedema—Vincristine—sarcoma	0.000368	0.00234	CcSEcCtD
Clomifene—Phlebitis—Doxorubicin—sarcoma	0.000365	0.00232	CcSEcCtD
Clomifene—CYP2E1—testis—sarcoma	0.000363	0.00631	CbGeAlD
Clomifene—Hot flush—Epirubicin—sarcoma	0.000363	0.00231	CcSEcCtD
Clomifene—Thrombophlebitis—Doxorubicin—sarcoma	0.000363	0.00231	CcSEcCtD
Clomifene—Increased appetite—Epirubicin—sarcoma	0.000362	0.0023	CcSEcCtD
Clomifene—Menopausal symptoms—Epirubicin—sarcoma	0.00036	0.00229	CcSEcCtD
Clomifene—Oedema—Mitoxantrone—sarcoma	0.000358	0.00228	CcSEcCtD
Clomifene—Fatigue—Thiotepa—sarcoma	0.000358	0.00227	CcSEcCtD
Clomifene—Fatigue—Dactinomycin—sarcoma	0.000355	0.00226	CcSEcCtD
Clomifene—Constipation—Thiotepa—sarcoma	0.000355	0.00225	CcSEcCtD
Clomifene—Pain—Thiotepa—sarcoma	0.000355	0.00225	CcSEcCtD
Clomifene—Back pain—Etoposide—sarcoma	0.000353	0.00224	CcSEcCtD
Clomifene—Shock—Mitoxantrone—sarcoma	0.000352	0.00224	CcSEcCtD
Clomifene—Pain—Dactinomycin—sarcoma	0.000352	0.00224	CcSEcCtD
Clomifene—Tachycardia—Mitoxantrone—sarcoma	0.00035	0.00222	CcSEcCtD
Clomifene—Eye pain—Doxorubicin—sarcoma	0.000348	0.00221	CcSEcCtD
Clomifene—CYP2A6—Fluoropyrimidine Activity—SMUG1—sarcoma	0.000348	0.0136	CbGpPWpGaD
Clomifene—Cerebrovascular accident—Epirubicin—sarcoma	0.000347	0.0022	CcSEcCtD
Clomifene—CYP2E1—liver—sarcoma	0.000344	0.00597	CbGeAlD
Clomifene—KCNH2—lymph node—sarcoma	0.000342	0.00594	CbGeAlD
Clomifene—Diplopia—Epirubicin—sarcoma	0.00034	0.00216	CcSEcCtD
Clomifene—Hot flush—Doxorubicin—sarcoma	0.000336	0.00214	CcSEcCtD
Clomifene—Musculoskeletal discomfort—Vincristine—sarcoma	0.000335	0.00213	CcSEcCtD
Clomifene—Increased appetite—Doxorubicin—sarcoma	0.000335	0.00213	CcSEcCtD
Clomifene—Migraine—Epirubicin—sarcoma	0.000334	0.00213	CcSEcCtD
Clomifene—Affect lability—Epirubicin—sarcoma	0.000334	0.00213	CcSEcCtD
Clomifene—Menopausal symptoms—Doxorubicin—sarcoma	0.000333	0.00212	CcSEcCtD
Clomifene—Insomnia—Vincristine—sarcoma	0.000333	0.00211	CcSEcCtD
Clomifene—ESR1—Estrogen Receptor Pathway—JUN—sarcoma	0.000331	0.013	CbGpPWpGaD
Clomifene—Paraesthesia—Vincristine—sarcoma	0.00033	0.0021	CcSEcCtD
Clomifene—Urticaria—Thiotepa—sarcoma	0.000329	0.00209	CcSEcCtD
Clomifene—Vertigo—Etoposide—sarcoma	0.000328	0.00208	CcSEcCtD
Clomifene—Body temperature increased—Thiotepa—sarcoma	0.000328	0.00208	CcSEcCtD
Clomifene—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.000326	0.00207	CcSEcCtD
Clomifene—Body temperature increased—Dactinomycin—sarcoma	0.000325	0.00207	CcSEcCtD
Clomifene—Mood swings—Epirubicin—sarcoma	0.000322	0.00205	CcSEcCtD
Clomifene—Paraesthesia—Mitoxantrone—sarcoma	0.000322	0.00204	CcSEcCtD
Clomifene—Loss of consciousness—Etoposide—sarcoma	0.000321	0.00204	CcSEcCtD
Clomifene—Cerebrovascular accident—Doxorubicin—sarcoma	0.000321	0.00204	CcSEcCtD
Clomifene—Dyspnoea—Mitoxantrone—sarcoma	0.000319	0.00203	CcSEcCtD
Clomifene—Fatigue—Vincristine—sarcoma	0.000317	0.00202	CcSEcCtD
Clomifene—Convulsion—Etoposide—sarcoma	0.000316	0.00201	CcSEcCtD
Clomifene—CYP11A1—Corticotropin-releasing hormone—PLCG1—sarcoma	0.000316	0.0123	CbGpPWpGaD
Clomifene—Hypertension—Etoposide—sarcoma	0.000315	0.002	CcSEcCtD
Clomifene—Constipation—Vincristine—sarcoma	0.000315	0.002	CcSEcCtD
Clomifene—Pain—Vincristine—sarcoma	0.000315	0.002	CcSEcCtD
Clomifene—Diplopia—Doxorubicin—sarcoma	0.000314	0.002	CcSEcCtD
Clomifene—ESR1—Regulation of Telomerase—WT1—sarcoma	0.000313	0.0122	CbGpPWpGaD
Clomifene—Chest pain—Etoposide—sarcoma	0.000311	0.00198	CcSEcCtD
Clomifene—Affect lability—Doxorubicin—sarcoma	0.000309	0.00197	CcSEcCtD
Clomifene—Migraine—Doxorubicin—sarcoma	0.000309	0.00197	CcSEcCtD
Clomifene—Fatigue—Mitoxantrone—sarcoma	0.000309	0.00196	CcSEcCtD
Clomifene—Constipation—Mitoxantrone—sarcoma	0.000306	0.00195	CcSEcCtD
Clomifene—Pain—Mitoxantrone—sarcoma	0.000306	0.00195	CcSEcCtD
Clomifene—Hypersensitivity—Thiotepa—sarcoma	0.000306	0.00194	CcSEcCtD
Clomifene—Hypersensitivity—Dactinomycin—sarcoma	0.000303	0.00193	CcSEcCtD
Clomifene—Mood swings—Doxorubicin—sarcoma	0.000298	0.00189	CcSEcCtD
Clomifene—Asthenia—Thiotepa—sarcoma	0.000298	0.00189	CcSEcCtD
Clomifene—Abdominal distension—Epirubicin—sarcoma	0.000296	0.00188	CcSEcCtD
Clomifene—Asthenia—Dactinomycin—sarcoma	0.000295	0.00188	CcSEcCtD
Clomifene—Pruritus—Thiotepa—sarcoma	0.000293	0.00187	CcSEcCtD
Clomifene—ESR1—Regulation of nuclear SMAD2/3 signaling—MYOD1—sarcoma	0.000293	0.0114	CbGpPWpGaD
Clomifene—ESR1—Estrogen signaling pathway—CREB1—sarcoma	0.000292	0.0114	CbGpPWpGaD
Clomifene—Tachycardia—Etoposide—sarcoma	0.000291	0.00185	CcSEcCtD
Clomifene—Body temperature increased—Vincristine—sarcoma	0.000291	0.00185	CcSEcCtD
Clomifene—CYP1A1—lymph node—sarcoma	0.000289	0.00502	CbGeAlD
Clomifene—Pancreatitis—Epirubicin—sarcoma	0.000288	0.00183	CcSEcCtD
Clomifene—CYP19A1—FSH signaling pathway—CREB1—sarcoma	0.000287	0.0112	CbGpPWpGaD
Clomifene—ABCB1—uterus—sarcoma	0.000285	0.00495	CbGeAlD
Clomifene—Urticaria—Mitoxantrone—sarcoma	0.000285	0.00181	CcSEcCtD
Clomifene—Diarrhoea—Thiotepa—sarcoma	0.000284	0.0018	CcSEcCtD
Clomifene—Body temperature increased—Mitoxantrone—sarcoma	0.000283	0.0018	CcSEcCtD
Clomifene—Diarrhoea—Dactinomycin—sarcoma	0.000282	0.00179	CcSEcCtD
Clomifene—CYP3A4—liver—sarcoma	0.000276	0.0048	CbGeAlD
Clomifene—CYP2A6—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	0.000275	0.0107	CbGpPWpGaD
Clomifene—Dizziness—Thiotepa—sarcoma	0.000274	0.00174	CcSEcCtD
Clomifene—Abdominal distension—Doxorubicin—sarcoma	0.000274	0.00174	CcSEcCtD
Clomifene—Pollakiuria—Epirubicin—sarcoma	0.000271	0.00172	CcSEcCtD
Clomifene—Hypersensitivity—Vincristine—sarcoma	0.000271	0.00172	CcSEcCtD
Clomifene—Paraesthesia—Etoposide—sarcoma	0.000268	0.0017	CcSEcCtD
Clomifene—Weight increased—Epirubicin—sarcoma	0.000267	0.0017	CcSEcCtD
Clomifene—Pancreatitis—Doxorubicin—sarcoma	0.000266	0.00169	CcSEcCtD
Clomifene—ESR1—Plasma membrane estrogen receptor signaling—IGF1R—sarcoma	0.000266	0.0104	CbGpPWpGaD
Clomifene—ABCB1—lymphoid tissue—sarcoma	0.000266	0.00462	CbGeAlD
Clomifene—Dyspnoea—Etoposide—sarcoma	0.000266	0.00169	CcSEcCtD
Clomifene—Hypersensitivity—Mitoxantrone—sarcoma	0.000264	0.00168	CcSEcCtD
Clomifene—Asthenia—Vincristine—sarcoma	0.000264	0.00168	CcSEcCtD
Clomifene—Vomiting—Thiotepa—sarcoma	0.000264	0.00168	CcSEcCtD
Clomifene—Vomiting—Dactinomycin—sarcoma	0.000262	0.00166	CcSEcCtD
Clomifene—Rash—Thiotepa—sarcoma	0.000262	0.00166	CcSEcCtD
Clomifene—Dermatitis—Thiotepa—sarcoma	0.000261	0.00166	CcSEcCtD
Clomifene—Headache—Thiotepa—sarcoma	0.00026	0.00165	CcSEcCtD
Clomifene—Rash—Dactinomycin—sarcoma	0.00026	0.00165	CcSEcCtD
Clomifene—Renal failure—Epirubicin—sarcoma	0.000257	0.00164	CcSEcCtD
Clomifene—Asthenia—Mitoxantrone—sarcoma	0.000257	0.00163	CcSEcCtD
Clomifene—Fatigue—Etoposide—sarcoma	0.000257	0.00163	CcSEcCtD
Clomifene—Jaundice—Epirubicin—sarcoma	0.000255	0.00162	CcSEcCtD
Clomifene—Pain—Etoposide—sarcoma	0.000255	0.00162	CcSEcCtD
Clomifene—Constipation—Etoposide—sarcoma	0.000255	0.00162	CcSEcCtD
Clomifene—Diarrhoea—Vincristine—sarcoma	0.000252	0.0016	CcSEcCtD
Clomifene—Pollakiuria—Doxorubicin—sarcoma	0.000251	0.0016	CcSEcCtD
Clomifene—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—JUN—sarcoma	0.00025	0.00976	CbGpPWpGaD
Clomifene—Weight increased—Doxorubicin—sarcoma	0.000247	0.00157	CcSEcCtD
Clomifene—Nausea—Thiotepa—sarcoma	0.000246	0.00157	CcSEcCtD
Clomifene—Diarrhoea—Mitoxantrone—sarcoma	0.000245	0.00156	CcSEcCtD
Clomifene—Nausea—Dactinomycin—sarcoma	0.000245	0.00155	CcSEcCtD
Clomifene—Dizziness—Vincristine—sarcoma	0.000243	0.00155	CcSEcCtD
Clomifene—ABCB1—bone marrow—sarcoma	0.000242	0.0042	CbGeAlD
Clomifene—Renal failure—Doxorubicin—sarcoma	0.000238	0.00151	CcSEcCtD
Clomifene—Urticaria—Etoposide—sarcoma	0.000237	0.0015	CcSEcCtD
Clomifene—Jaundice—Doxorubicin—sarcoma	0.000236	0.0015	CcSEcCtD
Clomifene—Body temperature increased—Etoposide—sarcoma	0.000236	0.0015	CcSEcCtD
Clomifene—Hepatitis—Epirubicin—sarcoma	0.000235	0.00149	CcSEcCtD
Clomifene—Vomiting—Vincristine—sarcoma	0.000234	0.00149	CcSEcCtD
Clomifene—Rash—Vincristine—sarcoma	0.000232	0.00147	CcSEcCtD
Clomifene—Dermatitis—Vincristine—sarcoma	0.000232	0.00147	CcSEcCtD
Clomifene—Headache—Vincristine—sarcoma	0.00023	0.00146	CcSEcCtD
Clomifene—Vomiting—Mitoxantrone—sarcoma	0.000228	0.00145	CcSEcCtD
Clomifene—Visual impairment—Epirubicin—sarcoma	0.000227	0.00144	CcSEcCtD
Clomifene—Rash—Mitoxantrone—sarcoma	0.000226	0.00144	CcSEcCtD
Clomifene—Dermatitis—Mitoxantrone—sarcoma	0.000226	0.00143	CcSEcCtD
Clomifene—Headache—Mitoxantrone—sarcoma	0.000224	0.00143	CcSEcCtD
Clomifene—Erythema multiforme—Epirubicin—sarcoma	0.000222	0.00141	CcSEcCtD
Clomifene—CYP1A1—Melatonin metabolism and effects—FOXO1—sarcoma	0.000222	0.00866	CbGpPWpGaD
Clomifene—ESR1—Leptin signaling pathway—PLCG1—sarcoma	0.00022	0.00862	CbGpPWpGaD
Clomifene—CYP1A1—Estrogen Receptor Pathway—JUN—sarcoma	0.00022	0.00858	CbGpPWpGaD
Clomifene—Hypersensitivity—Etoposide—sarcoma	0.000219	0.0014	CcSEcCtD
Clomifene—Tinnitus—Epirubicin—sarcoma	0.000219	0.00139	CcSEcCtD
Clomifene—Nausea—Vincristine—sarcoma	0.000218	0.00139	CcSEcCtD
Clomifene—Flushing—Epirubicin—sarcoma	0.000218	0.00139	CcSEcCtD
Clomifene—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—sarcoma	0.000218	0.00852	CbGpPWpGaD
Clomifene—Hepatitis—Doxorubicin—sarcoma	0.000217	0.00138	CcSEcCtD
Clomifene—Asthenia—Etoposide—sarcoma	0.000214	0.00136	CcSEcCtD
Clomifene—Nausea—Mitoxantrone—sarcoma	0.000213	0.00135	CcSEcCtD
Clomifene—Pruritus—Etoposide—sarcoma	0.000211	0.00134	CcSEcCtD
Clomifene—ESR1—Estrogen signaling pathway—JUN—sarcoma	0.00021	0.00821	CbGpPWpGaD
Clomifene—Arrhythmia—Epirubicin—sarcoma	0.00021	0.00133	CcSEcCtD
Clomifene—Visual impairment—Doxorubicin—sarcoma	0.00021	0.00133	CcSEcCtD
Clomifene—ESR1—Signaling mediated by p38-alpha and p38-beta—CREB1—sarcoma	0.000209	0.00816	CbGpPWpGaD
Clomifene—Alopecia—Epirubicin—sarcoma	0.000208	0.00132	CcSEcCtD
Clomifene—ABCB1—testis—sarcoma	0.000207	0.00359	CbGeAlD
Clomifene—Erythema multiforme—Doxorubicin—sarcoma	0.000206	0.00131	CcSEcCtD
Clomifene—Erythema—Epirubicin—sarcoma	0.000205	0.0013	CcSEcCtD
Clomifene—Diarrhoea—Etoposide—sarcoma	0.000204	0.0013	CcSEcCtD
Clomifene—Tinnitus—Doxorubicin—sarcoma	0.000203	0.00129	CcSEcCtD
Clomifene—Flushing—Doxorubicin—sarcoma	0.000202	0.00128	CcSEcCtD
Clomifene—Flatulence—Epirubicin—sarcoma	0.000202	0.00128	CcSEcCtD
Clomifene—Tension—Epirubicin—sarcoma	0.000201	0.00128	CcSEcCtD
Clomifene—Nervousness—Epirubicin—sarcoma	0.000199	0.00126	CcSEcCtD
Clomifene—Back pain—Epirubicin—sarcoma	0.000198	0.00126	CcSEcCtD
Clomifene—Dizziness—Etoposide—sarcoma	0.000197	0.00125	CcSEcCtD
Clomifene—ABCB1—liver—sarcoma	0.000196	0.0034	CbGeAlD
Clomifene—Arrhythmia—Doxorubicin—sarcoma	0.000194	0.00124	CcSEcCtD
Clomifene—Vision blurred—Epirubicin—sarcoma	0.000193	0.00123	CcSEcCtD
Clomifene—Alopecia—Doxorubicin—sarcoma	0.000192	0.00122	CcSEcCtD
Clomifene—Vomiting—Etoposide—sarcoma	0.000189	0.0012	CcSEcCtD
Clomifene—Erythema—Doxorubicin—sarcoma	0.000189	0.0012	CcSEcCtD
Clomifene—Rash—Etoposide—sarcoma	0.000188	0.00119	CcSEcCtD
Clomifene—Dermatitis—Etoposide—sarcoma	0.000188	0.00119	CcSEcCtD
Clomifene—Headache—Etoposide—sarcoma	0.000187	0.00119	CcSEcCtD
Clomifene—Flatulence—Doxorubicin—sarcoma	0.000187	0.00119	CcSEcCtD
Clomifene—ESR1—ATF-2 transcription factor network—PDGFRA—sarcoma	0.000186	0.00728	CbGpPWpGaD
Clomifene—Tension—Doxorubicin—sarcoma	0.000186	0.00118	CcSEcCtD
Clomifene—CYP19A1—FSH signaling pathway—SRC—sarcoma	0.000185	0.00723	CbGpPWpGaD
Clomifene—Nervousness—Doxorubicin—sarcoma	0.000184	0.00117	CcSEcCtD
Clomifene—Vertigo—Epirubicin—sarcoma	0.000184	0.00117	CcSEcCtD
Clomifene—Syncope—Epirubicin—sarcoma	0.000184	0.00117	CcSEcCtD
Clomifene—Back pain—Doxorubicin—sarcoma	0.000183	0.00116	CcSEcCtD
Clomifene—Palpitations—Epirubicin—sarcoma	0.000181	0.00115	CcSEcCtD
Clomifene—Loss of consciousness—Epirubicin—sarcoma	0.00018	0.00114	CcSEcCtD
Clomifene—Vision blurred—Doxorubicin—sarcoma	0.000178	0.00113	CcSEcCtD
Clomifene—Convulsion—Epirubicin—sarcoma	0.000177	0.00113	CcSEcCtD
Clomifene—ESR1—LKB1 signaling events—CREB1—sarcoma	0.000177	0.00692	CbGpPWpGaD
Clomifene—Nausea—Etoposide—sarcoma	0.000177	0.00112	CcSEcCtD
Clomifene—Hypertension—Epirubicin—sarcoma	0.000177	0.00112	CcSEcCtD
Clomifene—ABCB1—HIF-1-alpha transcription factor network—NPM1—sarcoma	0.000176	0.00687	CbGpPWpGaD
Clomifene—Arthralgia—Epirubicin—sarcoma	0.000174	0.00111	CcSEcCtD
Clomifene—Myalgia—Epirubicin—sarcoma	0.000174	0.00111	CcSEcCtD
Clomifene—Chest pain—Epirubicin—sarcoma	0.000174	0.00111	CcSEcCtD
Clomifene—Anxiety—Epirubicin—sarcoma	0.000174	0.0011	CcSEcCtD
Clomifene—ESR1—Plasma membrane estrogen receptor signaling—MMP2—sarcoma	0.000171	0.00669	CbGpPWpGaD
Clomifene—Vertigo—Doxorubicin—sarcoma	0.00017	0.00108	CcSEcCtD
Clomifene—Syncope—Doxorubicin—sarcoma	0.00017	0.00108	CcSEcCtD
Clomifene—ESR1—FOXM1 transcription factor network—MMP2—sarcoma	0.000168	0.00656	CbGpPWpGaD
Clomifene—Palpitations—Doxorubicin—sarcoma	0.000167	0.00106	CcSEcCtD
Clomifene—Oedema—Epirubicin—sarcoma	0.000167	0.00106	CcSEcCtD
Clomifene—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—sarcoma	0.000167	0.00652	CbGpPWpGaD
Clomifene—Loss of consciousness—Doxorubicin—sarcoma	0.000166	0.00106	CcSEcCtD
Clomifene—Shock—Epirubicin—sarcoma	0.000164	0.00104	CcSEcCtD
Clomifene—Convulsion—Doxorubicin—sarcoma	0.000164	0.00104	CcSEcCtD
Clomifene—ABCB1—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	0.000164	0.00639	CbGpPWpGaD
Clomifene—Hypertension—Doxorubicin—sarcoma	0.000163	0.00104	CcSEcCtD
Clomifene—Tachycardia—Epirubicin—sarcoma	0.000163	0.00104	CcSEcCtD
Clomifene—CYP11A1—Corticotropin-releasing hormone—CREB1—sarcoma	0.000162	0.00635	CbGpPWpGaD
Clomifene—Arthralgia—Doxorubicin—sarcoma	0.000161	0.00102	CcSEcCtD
Clomifene—Chest pain—Doxorubicin—sarcoma	0.000161	0.00102	CcSEcCtD
Clomifene—Myalgia—Doxorubicin—sarcoma	0.000161	0.00102	CcSEcCtD
Clomifene—Anxiety—Doxorubicin—sarcoma	0.000161	0.00102	CcSEcCtD
Clomifene—ESR1—Leptin signaling pathway—FOXO1—sarcoma	0.000156	0.00611	CbGpPWpGaD
Clomifene—CYP19A1—Tryptophan metabolism—MDM2—sarcoma	0.000155	0.00606	CbGpPWpGaD
Clomifene—Oedema—Doxorubicin—sarcoma	0.000155	0.000982	CcSEcCtD
Clomifene—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000152	0.000967	CcSEcCtD
Clomifene—Shock—Doxorubicin—sarcoma	0.000152	0.000966	CcSEcCtD
Clomifene—Insomnia—Epirubicin—sarcoma	0.000151	0.00096	CcSEcCtD
Clomifene—Tachycardia—Doxorubicin—sarcoma	0.000151	0.000959	CcSEcCtD
Clomifene—ESR1—Signaling mediated by p38-alpha and p38-beta—JUN—sarcoma	0.00015	0.00587	CbGpPWpGaD
Clomifene—ABCB1—lymph node—sarcoma	0.00015	0.00261	CbGeAlD
Clomifene—Paraesthesia—Epirubicin—sarcoma	0.00015	0.000953	CcSEcCtD
Clomifene—Dyspnoea—Epirubicin—sarcoma	0.000149	0.000947	CcSEcCtD
Clomifene—ESR1—Regulation of nuclear SMAD2/3 signaling—FOXO1—sarcoma	0.000147	0.00575	CbGpPWpGaD
Clomifene—Fatigue—Epirubicin—sarcoma	0.000144	0.000915	CcSEcCtD
Clomifene—Constipation—Epirubicin—sarcoma	0.000143	0.000908	CcSEcCtD
Clomifene—Pain—Epirubicin—sarcoma	0.000143	0.000908	CcSEcCtD
Clomifene—CYP1A2—Melatonin metabolism and effects—FOXO1—sarcoma	0.000141	0.00552	CbGpPWpGaD
Clomifene—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000141	0.000895	CcSEcCtD
Clomifene—CYP1A2—Estrogen Receptor Pathway—JUN—sarcoma	0.00014	0.00547	CbGpPWpGaD
Clomifene—Insomnia—Doxorubicin—sarcoma	0.00014	0.000888	CcSEcCtD
Clomifene—Paraesthesia—Doxorubicin—sarcoma	0.000139	0.000882	CcSEcCtD
Clomifene—Dyspnoea—Doxorubicin—sarcoma	0.000138	0.000876	CcSEcCtD
Clomifene—ESR1—ATF-2 transcription factor network—CREB1—sarcoma	0.000137	0.00537	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—WT1—sarcoma	0.000137	0.00536	CbGpPWpGaD
Clomifene—CYP19A1—Integrated Breast Cancer Pathway—ATF1—sarcoma	0.000134	0.00522	CbGpPWpGaD
Clomifene—Fatigue—Doxorubicin—sarcoma	0.000133	0.000847	CcSEcCtD
Clomifene—Urticaria—Epirubicin—sarcoma	0.000133	0.000843	CcSEcCtD
Clomifene—Constipation—Doxorubicin—sarcoma	0.000132	0.00084	CcSEcCtD
Clomifene—Pain—Doxorubicin—sarcoma	0.000132	0.00084	CcSEcCtD
Clomifene—Body temperature increased—Epirubicin—sarcoma	0.000132	0.000839	CcSEcCtD
Clomifene—ESR1—FOXM1 transcription factor network—CCND1—sarcoma	0.00013	0.00508	CbGpPWpGaD
Clomifene—ESR1—ATF-2 transcription factor network—MMP2—sarcoma	0.000128	0.005	CbGpPWpGaD
Clomifene—ESR1—FOXA1 transcription factor network—JUN—sarcoma	0.000125	0.00489	CbGpPWpGaD
Clomifene—ABCB1—HIF-1-alpha transcription factor network—CXCR4—sarcoma	0.000124	0.00485	CbGpPWpGaD
Clomifene—Hypersensitivity—Epirubicin—sarcoma	0.000123	0.000782	CcSEcCtD
Clomifene—Urticaria—Doxorubicin—sarcoma	0.000123	0.00078	CcSEcCtD
Clomifene—Body temperature increased—Doxorubicin—sarcoma	0.000122	0.000777	CcSEcCtD
Clomifene—CYP11A1—Corticotropin-releasing hormone—IL2—sarcoma	0.00012	0.00469	CbGpPWpGaD
Clomifene—ESR1—AP-1 transcription factor network—CREB1—sarcoma	0.00012	0.00469	CbGpPWpGaD
Clomifene—Asthenia—Epirubicin—sarcoma	0.00012	0.000762	CcSEcCtD
Clomifene—ESR1—Integrated Breast Cancer Pathway—ATF1—sarcoma	0.00012	0.00468	CbGpPWpGaD
Clomifene—ESR1—Plasma membrane estrogen receptor signaling—SRC—sarcoma	0.000119	0.00464	CbGpPWpGaD
Clomifene—Pruritus—Epirubicin—sarcoma	0.000118	0.000751	CcSEcCtD
Clomifene—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRB—sarcoma	0.000116	0.00454	CbGpPWpGaD
Clomifene—CYP11A1—Corticotropin-releasing hormone—CTNNB1—sarcoma	0.000116	0.00453	CbGpPWpGaD
Clomifene—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—sarcoma	0.000114	0.00447	CbGpPWpGaD
Clomifene—Diarrhoea—Epirubicin—sarcoma	0.000114	0.000726	CcSEcCtD
Clomifene—ESR1—Plasma membrane estrogen receptor signaling—NRAS—sarcoma	0.000114	0.00446	CbGpPWpGaD
Clomifene—Hypersensitivity—Doxorubicin—sarcoma	0.000114	0.000724	CcSEcCtD
Clomifene—ESR1—Leptin signaling pathway—CREB1—sarcoma	0.000113	0.00443	CbGpPWpGaD
Clomifene—Asthenia—Doxorubicin—sarcoma	0.000111	0.000705	CcSEcCtD
Clomifene—Dizziness—Epirubicin—sarcoma	0.00011	0.000702	CcSEcCtD
Clomifene—Pruritus—Doxorubicin—sarcoma	0.000109	0.000695	CcSEcCtD
Clomifene—ESR1—Aryl Hydrocarbon Receptor—SRC—sarcoma	0.000108	0.00423	CbGpPWpGaD
Clomifene—ESR1—Regulation of nuclear SMAD2/3 signaling—CREB1—sarcoma	0.000107	0.00417	CbGpPWpGaD
Clomifene—Vomiting—Epirubicin—sarcoma	0.000106	0.000675	CcSEcCtD
Clomifene—Diarrhoea—Doxorubicin—sarcoma	0.000106	0.000672	CcSEcCtD
Clomifene—ESR1—Aryl Hydrocarbon Receptor—VEGFA—sarcoma	0.000105	0.00412	CbGpPWpGaD
Clomifene—Rash—Epirubicin—sarcoma	0.000105	0.000669	CcSEcCtD
Clomifene—Dermatitis—Epirubicin—sarcoma	0.000105	0.000669	CcSEcCtD
Clomifene—Headache—Epirubicin—sarcoma	0.000105	0.000665	CcSEcCtD
Clomifene—ESR1—FOXM1 transcription factor network—MYC—sarcoma	0.000104	0.00408	CbGpPWpGaD
Clomifene—ESR1—Aryl Hydrocarbon Receptor—NRAS—sarcoma	0.000104	0.00407	CbGpPWpGaD
Clomifene—ESR1—LKB1 signaling events—MYC—sarcoma	0.000102	0.004	CbGpPWpGaD
Clomifene—Dizziness—Doxorubicin—sarcoma	0.000102	0.00065	CcSEcCtD
Clomifene—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	0.000101	0.00394	CbGpPWpGaD
Clomifene—CYP19A1—Integrated Breast Cancer Pathway—FOXO1—sarcoma	9.98e-05	0.0039	CbGpPWpGaD
Clomifene—Nausea—Epirubicin—sarcoma	9.92e-05	0.000631	CcSEcCtD
Clomifene—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—sarcoma	9.91e-05	0.00387	CbGpPWpGaD
Clomifene—ESR1—ATF-2 transcription factor network—CCND1—sarcoma	9.9e-05	0.00387	CbGpPWpGaD
Clomifene—ESR1—ATF-2 transcription factor network—JUN—sarcoma	9.88e-05	0.00386	CbGpPWpGaD
Clomifene—Vomiting—Doxorubicin—sarcoma	9.82e-05	0.000625	CcSEcCtD
Clomifene—ESR1—Plasma membrane estrogen receptor signaling—KRAS—sarcoma	9.82e-05	0.00384	CbGpPWpGaD
Clomifene—KCNH2—SIDS Susceptibility Pathways—CREB1—sarcoma	9.8e-05	0.00383	CbGpPWpGaD
Clomifene—CYP2E1—Tryptophan metabolism—MDM2—sarcoma	9.75e-05	0.00381	CbGpPWpGaD
Clomifene—Rash—Doxorubicin—sarcoma	9.74e-05	0.000619	CcSEcCtD
Clomifene—Dermatitis—Doxorubicin—sarcoma	9.73e-05	0.000619	CcSEcCtD
Clomifene—ESR1—Aryl Hydrocarbon Receptor—MYC—sarcoma	9.69e-05	0.00379	CbGpPWpGaD
Clomifene—Headache—Doxorubicin—sarcoma	9.68e-05	0.000615	CcSEcCtD
Clomifene—ESR1—Aryl Hydrocarbon Receptor—EGFR—sarcoma	9.48e-05	0.00371	CbGpPWpGaD
Clomifene—ESR1—Validated nuclear estrogen receptor alpha network—CCND1—sarcoma	9.28e-05	0.00363	CbGpPWpGaD
Clomifene—ESR1—Validated nuclear estrogen receptor alpha network—JUN—sarcoma	9.26e-05	0.00362	CbGpPWpGaD
Clomifene—CYP2A6—Fluoropyrimidine Activity—TP53—sarcoma	9.23e-05	0.00361	CbGpPWpGaD
Clomifene—CYP1A1—Tryptophan metabolism—MDM2—sarcoma	9.19e-05	0.00359	CbGpPWpGaD
Clomifene—Nausea—Doxorubicin—sarcoma	9.18e-05	0.000583	CcSEcCtD
Clomifene—ESR1—Regulation of Telomerase—IL2—sarcoma	9.07e-05	0.00355	CbGpPWpGaD
Clomifene—ESR1—Aryl Hydrocarbon Receptor—KRAS—sarcoma	8.96e-05	0.0035	CbGpPWpGaD
Clomifene—ESR1—Integrated Breast Cancer Pathway—FOXO1—sarcoma	8.93e-05	0.00349	CbGpPWpGaD
Clomifene—EBP—Metabolism—ENO2—sarcoma	8.91e-05	0.00348	CbGpPWpGaD
Clomifene—ESR1—Signaling by ERBB4—FOXO1—sarcoma	8.89e-05	0.00347	CbGpPWpGaD
Clomifene—ESR1—Signaling by ERBB4—PDGFRB—sarcoma	8.87e-05	0.00347	CbGpPWpGaD
Clomifene—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—sarcoma	8.86e-05	0.00346	CbGpPWpGaD
Clomifene—ESR1—AP-1 transcription factor network—IL2—sarcoma	8.86e-05	0.00346	CbGpPWpGaD
Clomifene—EBP—Metabolism—HBA1—sarcoma	8.86e-05	0.00346	CbGpPWpGaD
Clomifene—ESR1—Regulation of Telomerase—CCND1—sarcoma	8.84e-05	0.00346	CbGpPWpGaD
Clomifene—ESR1—Regulation of Telomerase—JUN—sarcoma	8.82e-05	0.00345	CbGpPWpGaD
Clomifene—ESR1—Signaling by ERBB4—PDGFRA—sarcoma	8.73e-05	0.00341	CbGpPWpGaD
Clomifene—ESR1—AP-1 transcription factor network—CCND1—sarcoma	8.64e-05	0.00338	CbGpPWpGaD
Clomifene—ESR1—AP-1 transcription factor network—JUN—sarcoma	8.62e-05	0.00337	CbGpPWpGaD
Clomifene—ESR1—AP-1 transcription factor network—CTNNB1—sarcoma	8.55e-05	0.00334	CbGpPWpGaD
Clomifene—ESR1—LKB1 signaling events—TP53—sarcoma	8.4e-05	0.00328	CbGpPWpGaD
Clomifene—ESR1—Plasma membrane estrogen receptor signaling—HRAS—sarcoma	8.35e-05	0.00326	CbGpPWpGaD
Clomifene—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—sarcoma	8.21e-05	0.00321	CbGpPWpGaD
Clomifene—ESR1—Leptin signaling pathway—CCND1—sarcoma	8.17e-05	0.0032	CbGpPWpGaD
Clomifene—CYP1A1—Aryl Hydrocarbon Receptor Pathway—JUN—sarcoma	7.99e-05	0.00312	CbGpPWpGaD
Clomifene—ABCB1—Allograft Rejection—PDGFRA—sarcoma	7.8e-05	0.00305	CbGpPWpGaD
Clomifene—ESR1—Regulation of nuclear SMAD2/3 signaling—JUN—sarcoma	7.67e-05	0.003	CbGpPWpGaD
Clomifene—ESR1—Aryl Hydrocarbon Receptor—HRAS—sarcoma	7.61e-05	0.00298	CbGpPWpGaD
Clomifene—EBP—Metabolism—PLCG1—sarcoma	7.56e-05	0.00296	CbGpPWpGaD
Clomifene—ESR1—Validated nuclear estrogen receptor alpha network—MYC—sarcoma	7.44e-05	0.00291	CbGpPWpGaD
Clomifene—ESR1—Leptin signaling pathway—SRC—sarcoma	7.32e-05	0.00286	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—PDGFRA—sarcoma	7.28e-05	0.00284	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—sarcoma	7.25e-05	0.00284	CbGpPWpGaD
Clomifene—CYP19A1—Integrated Breast Cancer Pathway—CREB1—sarcoma	7.24e-05	0.00283	CbGpPWpGaD
Clomifene—CYP1A1—Aryl Hydrocarbon Receptor Pathway—SRC—sarcoma	7.17e-05	0.0028	CbGpPWpGaD
Clomifene—CYP1A1—Aryl Hydrocarbon Receptor—SRC—sarcoma	7.17e-05	0.0028	CbGpPWpGaD
Clomifene—ESR1—Regulation of Telomerase—MYC—sarcoma	7.09e-05	0.00277	CbGpPWpGaD
Clomifene—KCNH2—SIDS Susceptibility Pathways—JUN—sarcoma	7.05e-05	0.00275	CbGpPWpGaD
Clomifene—KCNH2—SIDS Susceptibility Pathways—CTNNB1—sarcoma	6.99e-05	0.00273	CbGpPWpGaD
Clomifene—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—sarcoma	6.98e-05	0.00273	CbGpPWpGaD
Clomifene—ESR1—Regulation of Telomerase—EGFR—sarcoma	6.94e-05	0.00271	CbGpPWpGaD
Clomifene—ESR1—AP-1 transcription factor network—MYC—sarcoma	6.93e-05	0.00271	CbGpPWpGaD
Clomifene—CYP1A1—Aryl Hydrocarbon Receptor—NRAS—sarcoma	6.89e-05	0.00269	CbGpPWpGaD
Clomifene—ESR1—Signaling by ERBB4—KIT—sarcoma	6.77e-05	0.00265	CbGpPWpGaD
Clomifene—ABCB1—HIF-1-alpha transcription factor network—CREB1—sarcoma	6.65e-05	0.0026	CbGpPWpGaD
Clomifene—ESR1—Integrated Breast Cancer Pathway—CREB1—sarcoma	6.48e-05	0.00253	CbGpPWpGaD
Clomifene—ESR1—Signaling by ERBB4—CREB1—sarcoma	6.45e-05	0.00252	CbGpPWpGaD
Clomifene—CYP1A1—Aryl Hydrocarbon Receptor—MYC—sarcoma	6.42e-05	0.00251	CbGpPWpGaD
Clomifene—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—sarcoma	6.28e-05	0.00246	CbGpPWpGaD
Clomifene—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—sarcoma	6.28e-05	0.00246	CbGpPWpGaD
Clomifene—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—sarcoma	6.17e-05	0.00241	CbGpPWpGaD
Clomifene—KCNH2—SIDS Susceptibility Pathways—VEGFA—sarcoma	6.16e-05	0.00241	CbGpPWpGaD
Clomifene—KCNH2—Neuronal System—CREB1—sarcoma	6.15e-05	0.00241	CbGpPWpGaD
Clomifene—CYP19A1—Integrated Breast Cancer Pathway—MDM2—sarcoma	5.99e-05	0.00234	CbGpPWpGaD
Clomifene—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—sarcoma	5.93e-05	0.00232	CbGpPWpGaD
Clomifene—CYP1A2—Tryptophan metabolism—MDM2—sarcoma	5.86e-05	0.00229	CbGpPWpGaD
Clomifene—ESR1—Gene Expression—FUS—sarcoma	5.71e-05	0.00223	CbGpPWpGaD
Clomifene—ESR1—AP-1 transcription factor network—TP53—sarcoma	5.69e-05	0.00222	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	5.37e-05	0.0021	CbGpPWpGaD
Clomifene—ESR1—Integrated Breast Cancer Pathway—MDM2—sarcoma	5.36e-05	0.0021	CbGpPWpGaD
Clomifene—ESR1—Signaling by ERBB4—MDM2—sarcoma	5.33e-05	0.00208	CbGpPWpGaD
Clomifene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—sarcoma	5.24e-05	0.00205	CbGpPWpGaD
Clomifene—CYP19A1—Integrated Breast Cancer Pathway—CCND1—sarcoma	5.22e-05	0.00204	CbGpPWpGaD
Clomifene—CYP19A1—Integrated Breast Cancer Pathway—JUN—sarcoma	5.21e-05	0.00203	CbGpPWpGaD
Clomifene—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—sarcoma	5.17e-05	0.00202	CbGpPWpGaD
Clomifene—ESR1—Leptin signaling pathway—HRAS—sarcoma	5.15e-05	0.00201	CbGpPWpGaD
Clomifene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—sarcoma	5.09e-05	0.00199	CbGpPWpGaD
Clomifene—KCNH2—Neuronal System—MDM2—sarcoma	5.09e-05	0.00199	CbGpPWpGaD
Clomifene—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—sarcoma	5.04e-05	0.00197	CbGpPWpGaD
Clomifene—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—sarcoma	4.88e-05	0.00191	CbGpPWpGaD
Clomifene—ABCB1—HIF-1-alpha transcription factor network—JUN—sarcoma	4.78e-05	0.00187	CbGpPWpGaD
Clomifene—ESR1—Integrated Breast Cancer Pathway—CCND1—sarcoma	4.67e-05	0.00183	CbGpPWpGaD
Clomifene—ESR1—Integrated Breast Cancer Pathway—JUN—sarcoma	4.66e-05	0.00182	CbGpPWpGaD
Clomifene—ESR1—Integrated Breast Cancer Pathway—CTNNB1—sarcoma	4.62e-05	0.00181	CbGpPWpGaD
Clomifene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—sarcoma	4.57e-05	0.00179	CbGpPWpGaD
Clomifene—CYP1A2—Aryl Hydrocarbon Receptor—SRC—sarcoma	4.57e-05	0.00179	CbGpPWpGaD
Clomifene—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—sarcoma	4.55e-05	0.00178	CbGpPWpGaD
Clomifene—CYP3A4—Tryptophan metabolism—MDM2—sarcoma	4.52e-05	0.00177	CbGpPWpGaD
Clomifene—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—sarcoma	4.45e-05	0.00174	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	4.44e-05	0.00174	CbGpPWpGaD
Clomifene—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—sarcoma	4.4e-05	0.00172	CbGpPWpGaD
Clomifene—ABCB1—Allograft Rejection—IL2—sarcoma	4.26e-05	0.00166	CbGpPWpGaD
Clomifene—CYP19A1—Integrated Breast Cancer Pathway—MYC—sarcoma	4.18e-05	0.00164	CbGpPWpGaD
Clomifene—ABCB1—HIF-1-alpha transcription factor network—VEGFA—sarcoma	4.18e-05	0.00163	CbGpPWpGaD
Clomifene—CYP1A2—Aryl Hydrocarbon Receptor—MYC—sarcoma	4.09e-05	0.0016	CbGpPWpGaD
Clomifene—CYP19A1—Integrated Breast Cancer Pathway—EGFR—sarcoma	4.09e-05	0.0016	CbGpPWpGaD
Clomifene—ESR1—Integrated Breast Cancer Pathway—VEGFA—sarcoma	4.07e-05	0.00159	CbGpPWpGaD
Clomifene—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—sarcoma	4.01e-05	0.00157	CbGpPWpGaD
Clomifene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—sarcoma	4.01e-05	0.00157	CbGpPWpGaD
Clomifene—ESR1—Signaling by ERBB4—NRAS—sarcoma	4e-05	0.00156	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	3.87e-05	0.00151	CbGpPWpGaD
Clomifene—CYP19A1—Integrated Breast Cancer Pathway—KRAS—sarcoma	3.87e-05	0.00151	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	3.86e-05	0.00151	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—ENO2—sarcoma	3.86e-05	0.00151	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—sarcoma	3.85e-05	0.0015	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	3.83e-05	0.0015	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—HBA1—sarcoma	3.83e-05	0.0015	CbGpPWpGaD
Clomifene—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—sarcoma	3.78e-05	0.00148	CbGpPWpGaD
Clomifene—ESR1—Integrated Breast Cancer Pathway—MYC—sarcoma	3.75e-05	0.00146	CbGpPWpGaD
Clomifene—ESR1—Integrated Breast Cancer Pathway—EGFR—sarcoma	3.66e-05	0.00143	CbGpPWpGaD
Clomifene—ESR1—Signaling by ERBB4—EGFR—sarcoma	3.64e-05	0.00142	CbGpPWpGaD
Clomifene—ABCB1—Allograft Rejection—VEGFA—sarcoma	3.62e-05	0.00141	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	3.46e-05	0.00135	CbGpPWpGaD
Clomifene—ESR1—Integrated Breast Cancer Pathway—KRAS—sarcoma	3.46e-05	0.00135	CbGpPWpGaD
Clomifene—ESR1—Signaling by ERBB4—KRAS—sarcoma	3.44e-05	0.00135	CbGpPWpGaD
Clomifene—CYP19A1—Integrated Breast Cancer Pathway—TP53—sarcoma	3.44e-05	0.00134	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	3.37e-05	0.00132	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—PLCG1—sarcoma	3.27e-05	0.00128	CbGpPWpGaD
Clomifene—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—sarcoma	3.22e-05	0.00126	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	3.1e-05	0.00121	CbGpPWpGaD
Clomifene—ESR1—Integrated Breast Cancer Pathway—TP53—sarcoma	3.08e-05	0.0012	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	3.04e-05	0.00119	CbGpPWpGaD
Clomifene—ESR1—Signaling by ERBB4—HRAS—sarcoma	2.93e-05	0.00114	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	2.87e-05	0.00112	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	2.84e-05	0.00111	CbGpPWpGaD
Clomifene—KCNH2—Neuronal System—HRAS—sarcoma	2.79e-05	0.00109	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—ENO2—sarcoma	2.55e-05	0.000998	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	2.55e-05	0.000996	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—HBA1—sarcoma	2.54e-05	0.000992	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—TLE1—sarcoma	2.45e-05	0.000957	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	2.35e-05	0.000919	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—PLCG1—sarcoma	2.17e-05	0.000847	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—VEGFC—sarcoma	2.06e-05	0.000807	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	2.05e-05	0.0008	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	2.04e-05	0.000799	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—ENO2—sarcoma	2.03e-05	0.000795	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	2.03e-05	0.000793	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—HBA1—sarcoma	2.02e-05	0.00079	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	1.83e-05	0.000716	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	1.78e-05	0.000698	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—PLCG1—sarcoma	1.73e-05	0.000674	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—FLT1—sarcoma	1.65e-05	0.000645	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	1.64e-05	0.000642	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—PLCG1—sarcoma	1.62e-05	0.000634	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—ENO2—sarcoma	1.61e-05	0.000628	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	1.61e-05	0.000628	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—HBA1—sarcoma	1.6e-05	0.000624	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—CXCR4—sarcoma	1.56e-05	0.000609	CbGpPWpGaD
Clomifene—ESR1—Generic Transcription Pathway—MYC—sarcoma	1.54e-05	0.000603	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—ATF1—sarcoma	1.54e-05	0.000602	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	1.52e-05	0.000593	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—ENO2—sarcoma	1.51e-05	0.000592	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—HBA1—sarcoma	1.51e-05	0.000588	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—PLCG1—sarcoma	1.36e-05	0.000533	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	1.35e-05	0.000527	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—PLCG1—sarcoma	1.29e-05	0.000502	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—ENO2—sarcoma	1.21e-05	0.000473	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—IGF1R—sarcoma	1.21e-05	0.000473	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—HBA1—sarcoma	1.2e-05	0.00047	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—FOXO1—sarcoma	1.15e-05	0.00045	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—PDGFRB—sarcoma	1.15e-05	0.000449	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—PDGFRA—sarcoma	1.13e-05	0.000442	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—PLCG1—sarcoma	1.03e-05	0.000401	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—ENO2—sarcoma	9.66e-06	0.000378	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—HBA1—sarcoma	9.6e-06	0.000375	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—KDR—sarcoma	9.52e-06	0.000372	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—KIT—sarcoma	8.77e-06	0.000343	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—CREB1—sarcoma	8.35e-06	0.000326	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—PLCG1—sarcoma	8.2e-06	0.00032	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—ENO2—sarcoma	7.45e-06	0.000291	CbGpPWpGaD
Clomifene—ESR1—Gene Expression—MYC—sarcoma	7.42e-06	0.00029	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—HBA1—sarcoma	7.41e-06	0.00029	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—MDM2—sarcoma	6.91e-06	0.00027	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—PLCG1—sarcoma	6.32e-06	0.000247	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—IL2—sarcoma	6.17e-06	0.000241	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—CCND1—sarcoma	6.02e-06	0.000235	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—JUN—sarcoma	6e-06	0.000235	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—CTNNB1—sarcoma	5.96e-06	0.000233	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—SRC—sarcoma	5.39e-06	0.000211	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—VEGFA—sarcoma	5.25e-06	0.000205	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—NRAS—sarcoma	5.18e-06	0.000203	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—MYC—sarcoma	4.83e-06	0.000189	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—EGFR—sarcoma	4.72e-06	0.000185	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—KRAS—sarcoma	4.46e-06	0.000174	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—TP53—sarcoma	3.96e-06	0.000155	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—HRAS—sarcoma	3.79e-06	0.000148	CbGpPWpGaD
